Myopathy, Scapuloperoneal

National Organization for Rare Disorders, Inc.

Skip to the navigation


It is possible that the main title of the report Myopathy, Scapuloperoneal is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.


  • Scapuloperoneal Muscular Dystrophy
  • Scapuloperoneal Syndrome, Myopathic Type

Disorder Subdivisions

  • None

General Discussion

Scapuloperoneal myopathy is a rare genetic disorder characterized by weakness and wasting of certain muscles. Symptoms are usually limited to the shoulder blade area (scapula) and the smaller of the two leg muscle groups below the knee (peroneal). Facial muscles may be affected in a few cases. The leg symptoms often appear before the shoulder muscles become weakened. The rate of progression of the disorder varies from case to case. This condition can also occur in combination with other disorders. Scapuloperoneal myopathy is inherited as an autosomal dominant trait.


Symptoms of scapuloperoneal myopathy primarily include muscle weakness and wasting usually limited to muscles in the shoulder blade and girdle area and the legs below the knees. This disorder can begin in childhood or adulthood. The progression rate and severity may vary greatly, with some cases progressing more quickly than others. In most cases, the progression is slow.

The shoulder muscles are affected first, in most cases. In some cases, shoulder involvement may precede lower leg involvement by years or decades. In some cases, lower leg involvement may precede shoulder involvement. In rare cases, some facial muscles may be mildly affected.


Scapuloperoneal myopathy is inherited as an autosomal dominant trait. Human traits including the classic genetic diseases, are the product of the interaction of two genes for that condition, one received from the father and one from the mother.

In dominant disorders, a single copy of the disease gene (received from either the mother or father) will be expressed "dominating" the other normal gene and resulting in the appearance of the disease. The risk of transmitting the disorder from affected parent to offspring is 50 percent for each pregnancy regardless of the sex of the resulting child.

In some cases, scapuloperoneal myopathy may be due to new genetic changes (mutations) that appear to occur spontaneously for unknown reasons (sporadically).

Investigators have determined that some cases of scapuloperoneal myopathy may be caused by disruption or changes (mutations) of a gene located on the long arm (q) of chromosome 12 (12q13.3-q15). Chromosomes are found in the nucleus of all body cells. They carry the genetic characteristics of each individual. Pairs of human chromosomes are numbered from 1 through 22, with an unequal 23rd pair of X and Y chromosomes for males and two X chromosomes for females. Each chromosome has a short arm designated as "p" and a long arm identified by the letter "q." Chromosomes are further subdivided into bands that are numbered. For example, "chromosome 12q13.3-q15" refers to bands 13.3-15 on the long arm of chromosome 12.

Affected Populations

Scapuloperoneal myopathy affects males and females in equal numbers. Symptoms may begin in childhood or during adulthood. Scapuloperoneal myopathy is a rare disorder; the exact prevalence of this disorder in the general population is unknown.

Standard Therapies

There is no specific treatment for individuals with scapuloperoneal myopathy. Treatment may include specified amounts of therapeutic exercise and physical therapy alternating with periods of rest.

Genetic counseling may benefit affected individuals and their families. Other treatment is symptomatic and supportive.

Investigational Therapies

Information on current clinical trials is posted on the Internet at All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.

For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:

Tollfree: (800) 411-1222

TTY: (866) 411-1010


For information about clinical trials sponsored by private sources, contact:



Pal E, et al. Familial scapuloperoneal myopathy and mitochondrial DNA defect. Eur Neurol. 1999;42:211-16.

Milanov I, et al. Differential diagnosis of scapuloperoneal syndrome. Electromyogr Clin Neurophysiol. 1997;37:73-78.

Wilhelmsen KC, et al. Chromosome 12-linked autosomal dominant scapuloperoneal muscular dystrophy. Ann Neurol. 1996;39:507-20.

Isozumi K, et al. Linkage of scapuloperoneal spinal muscular atrophy to chromosome 12q24.1-q24.31. Hum Mol Genet. 1996;5:1377-82.

Emery AE, et al. Emery-Dreifuss muscular dystrophy and other related disorders. Br. Med Bull. 1989;45:772-87.

Yee WC, et al. Adult onset scapuloperoneal myopathy: diagnostic value of nerve morphometry and multiple muscle biopsies. J Neurol Neurosurg Psychiatry. 1988;51:808-13.

Wagner MB, et al. Serial isokinetic evaluations used for a patient with scapuloperoneal muscular dystrophy. Phys Ther. 1986;66:1110-13.

Todman DH, et al. Scapuloperoneal myopathy. Clin Exp Neurol. 1984;20:169-74.

Spalke G, et al. The differential diagnosis of scapuloperoneal amyotrophy. J Neurol. 1976;15:253-69.

Thomas PK, et al Adult onset scapuloperoneal myopathy. J Neurol Neurosurg Psychiatry. 1975;38:1008-15.


McKusick VA, ed. Online Mendelian Inheritance in Man (OMIM). Baltimore. MD: The Johns Hopkins University; Entry No:181430; Last Update:10/23/96.

McKusick VA, ed. Online Mendelian Inheritance in Man (OMIM). Baltimore. MD: The Johns Hopkins University; Entry No:181400; Last Update:3/13/98.


Muscular Dystrophy Association

3300 East Sunrise Drive

Tucson, AZ 85718-3208


Tel: (520)529-2000

Fax: (520)529-5300

Tel: (800)572-1717



NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases

Information Clearinghouse

One AMS Circle

Bethesda, MD 20892-3675


Tel: (301)495-4484

Fax: (301)718-6366

Tel: (877)226-4267

TDD: (301)565-2966



Genetic and Rare Diseases (GARD) Information Center

PO Box 8126

Gaithersburg, MD 20898-8126

Tel: (301)251-4925

Fax: (301)251-4911

Tel: (888)205-2311

TDD: (888)205-3223


For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see